Outcome of highly active antiretroviral therapy in HIV- infected Indian children

被引：0
|
作者：
Aparna Mukherjee
Nipam Shah
Ravinder Singh
Madhu Vajpayee
Sushil K Kabra
Rakesh Lodha
机构：
[1] All India Institute of Medical Sciences,Departments of Pediatrics and Microbiology
来源：
BMC Infectious Diseases | / 14卷
关键词：
HIV; Children; Highly active antiretroviral therapy; Long-term outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Increased lipodystrophy is associated with increased exposure to highly active Antiretroviral therapy in HIV-infected children
    Viganò, A
    Mora, S
    Testolin, C
    Beccio, S
    Schneider, L
    Bricalli, D
    Vanzulli, A
    Manzoni, P
    Brambilla, P
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) : 482 - 489
  • [32] Persistence of Stunting After Highly Active Antiretroviral Therapy in HIV-Infected Children in South India
    Devi, N. Poorana Ganga
    Chandrasekaran, K.
    Bhavani, P. K.
    Thiruvalluvan, C.
    Swaminathan, Soumya
    [J]. INDIAN PEDIATRICS, 2011, 48 (04) : 333 - 334
  • [33] Immunological and virological effects of highly active antiretroviral therapy in two HIV-1 infected children
    Leon, JA
    Leal, M
    Lissen, E
    Gurbindo, D
    Muñoz-Fernández, MA
    [J]. ACTA PAEDIATRICA, 2000, 89 (03) : 373 - 374
  • [34] Body fat changes and lipodystrophy in HIV-infected children - Impact of highly active antiretroviral therapy
    Dzwonek, Agnieszka B.
    Lawson, Margaret S.
    Cole, Tim J.
    Novelli, Vas
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) : 121 - 123
  • [35] Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?
    M. I. Spagnuolo
    E. Bruzzese
    G. F. Vallone
    N. Fasano
    G. De Marco
    A. Officioso
    G. Valerio
    M. Volpicelli
    R. Iorio
    A. Franzese
    A. Guarino
    [J]. Journal of Endocrinological Investigation, 2008, 31 : 592 - 596
  • [36] Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?
    Spagnuolo, M. I.
    Bruzzese, E.
    Vallone, G. F.
    Fasano, N.
    De Marco, G.
    Officioso, A.
    Valerio, G.
    Volpicelli, M.
    Iorio, R.
    Franzese, A.
    Guarino, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (07) : 592 - 596
  • [37] Impact of Highly Active Antiretroviral Therapy (HAART) on Organs of HIV Infected Children in Abia State, Nigeria
    Ajulo, M. O.
    Omole, M. K.
    Moody, J. O.
    [J]. BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (07): : 837 - 848
  • [38] High rate of thyroid dysfunction in HIV-infected children receiving highly active antiretroviral therapy
    Viganò, A
    Riboni, S
    Bianchi, R
    Beccio, S
    Vago, T
    di Natale, B
    [J]. ANTIVIRAL THERAPY, 2002, 7 (03) : L62 - L63
  • [39] Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy
    Urschel, S
    Ramos, J
    Mellado, M
    Giaquinto, C
    Verweel, G
    Schuster, T
    Niehues, T
    Belohradsky, B
    Wintergerst, U
    [J]. AIDS, 2005, 19 (18) : 2103 - 2108
  • [40] Reported adherence as a determinant of response to highly active antiretroviral therapy (HAART) in HIV-infected children
    Van Dyke, RB
    Lee, S
    Stanley, K
    Johnson, GM
    Morse, EV
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 279A - 279A
12345